Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L POOL

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Human Hypertension|May 20, 1999
Dose-response efficacy of valsartan, a new angiotensin II receptor blockerJ L Pool, R Glazer, Y T Chiang, et al.
The American Journal of Medicine|February 1, 1987
Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. Beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposureA O Davies, A Mares, J L Pool, et al.
Clinical Toxicology|May 1, 1981
Tricyclic antidepressant overdose: clinical and pharmacologic observationsM B Nicotra, M Rivera, J L Pool, et al.
Cancer|June 15, 1984
The reach to recovery program. An evaluation of the attitudes of Connecticut surgeonsF C Sparks, J L Pool, S B Nuland, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1989
Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronateL E Mallette, A D LeBlanc, J L Pool, et al.
The American Journal of Medicine|October 1, 1987
Localization of ectopic pheochromocytomas by magnetic resonance imagingJ F Schmedtje, S Sax, J L Pool, et al.
Journal of Neurosurgery|November 1, 1987
Neurosurgical management of carotid sinus hypersensitivity. Report of three casesR K Simpson, J L Pool, R G Grossman, et al.
Journal of Clinical Pharmacology|May 11, 1999
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability studyA A Taylor, R Mangoo-Karim, K D Ballard, et al.
American Journal of Hypertension|January 1, 1997
Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertensionJ L Pool, W C Cushman, R K Saini, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 14, 1999
A 3-dimensional analysis of modes of cardiovascular adaptation: concepts, methods and preliminary findingsC D Jenkins, T Q Miller, L O Hewitt, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Human Hypertension|May 20, 1999
Dose-response efficacy of valsartan, a new angiotensin II receptor blockerJ L Pool, R Glazer, Y T Chiang, et al.
The American Journal of Medicine|February 1, 1987
Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. Beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposureA O Davies, A Mares, J L Pool, et al.
Clinical Toxicology|May 1, 1981
Tricyclic antidepressant overdose: clinical and pharmacologic observationsM B Nicotra, M Rivera, J L Pool, et al.
Cancer|June 15, 1984
The reach to recovery program. An evaluation of the attitudes of Connecticut surgeonsF C Sparks, J L Pool, S B Nuland, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1989
Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronateL E Mallette, A D LeBlanc, J L Pool, et al.
The American Journal of Medicine|October 1, 1987
Localization of ectopic pheochromocytomas by magnetic resonance imagingJ F Schmedtje, S Sax, J L Pool, et al.
Journal of Neurosurgery|November 1, 1987
Neurosurgical management of carotid sinus hypersensitivity. Report of three casesR K Simpson, J L Pool, R G Grossman, et al.
Journal of Clinical Pharmacology|May 11, 1999
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability studyA A Taylor, R Mangoo-Karim, K D Ballard, et al.
American Journal of Hypertension|January 1, 1997
Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertensionJ L Pool, W C Cushman, R K Saini, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 14, 1999
A 3-dimensional analysis of modes of cardiovascular adaptation: concepts, methods and preliminary findingsC D Jenkins, T Q Miller, L O Hewitt, et al.
Pageof 5